W Mark Saltzman Selected Research

W Mark Saltzman Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 12/2006
8	Glioma (Gliomas) 01/2019 - 01/2012
7	Brain Neoplasms (Brain Tumor) 01/2019 - 12/2006
7	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2002
4	Infections 01/2022 - 08/2012
4	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 02/2010
4	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2017 - 01/2003
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 04/2015
3	Thalassemia 01/2022 - 01/2018
3	Inflammation (Inflammations) 08/2014 - 03/2010
2	Lung Diseases (Lung Disease) 03/2022 - 01/2021
2	Meningomyelocele (Myelomeningocele) 03/2022 - 01/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 11/2013
2	HIV Infections (HIV Infection) 01/2018 - 10/2011
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 12/2015
2	Disease Progression 01/2017 - 02/2016
2	Lymphoma (Lymphomas) 02/2015 - 06/2012
2	Communicable Diseases (Infectious Diseases) 06/2009 - 06/2008
2	Hypoparathyroidism 12/2007 - 01/2005
1	COVID-19 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Atrophy 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Systemic Scleroderma (Systemic Sclerosis) 01/2021
1	Hypertrophy 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Congenital Diaphragmatic Hernias 01/2021
1	Ulcer 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Stroke (Strokes) 01/2019
1	Dermatitis 01/2019
1	Hemorrhage 01/2019
1	Hyperplasia 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2019
1	Myocardial Infarction 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018

Drug/Important Bio-Agent (IBA)

14	PolymersIBA 01/2021 - 01/2002
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
13	Pharmaceutical PreparationsIBA 01/2021 - 12/2006
7	Small Interfering RNA (siRNA)IBA 01/2021 - 06/2009
7	CamptothecinIBA 01/2021 - 01/2007
7	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2021 - 01/2007
4	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2020 - 02/2011
4	MicroRNAs (MicroRNA)IBA 12/2017 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2010
3	Peptide Nucleic AcidsIBA 01/2018 - 06/2012
3	Peptides (Polypeptides)IBA 12/2015 - 01/2012
3	GelsIBA 01/2009 - 01/2007
2	Messenger RNA (mRNA)IBA 03/2022 - 01/2021
2	AlginatesIBA 03/2022 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2020
2	AntibodiesIBA 01/2022 - 11/2017
2	poly(lactide) (polylactic acid)IBA 01/2021 - 05/2013
2	EmulsionsIBA 01/2019 - 08/2014
2	dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)IBA 01/2019 - 01/2018
2	NucleosidesIBA 01/2019 - 10/2016
2	Clostridium enterotoxinIBA 01/2017 - 12/2015
2	Claudin-3IBA 01/2017 - 12/2015
2	Fluorescent Dyes (Fluorescent Probes)IBA 12/2015 - 08/2014
2	VaccinesIBA 10/2010 - 06/2008
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2010 - 07/2004
2	CalciumIBA 12/2007 - 01/2005
2	Vitamin D FDA LinkGeneric 12/2007 - 01/2005
2	Parathyroid Hormone (Parathormone)IBA 12/2007 - 01/2005
1	Immunoglobulin A (IgA)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Tromethamine (Trometamol)FDA Link 01/2022
1	Drug CombinationsIBA 01/2022
1	OligonucleotidesIBA 01/2022
1	polyglycerolIBA 01/2021
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	Conditioned Culture MediaIBA 01/2021
1	Clodronic Acid (Clodronate)IBA 01/2021
1	phospholipid emulsion soybean oil (Intralipid)IBA 01/2021
1	OligodeoxyribonucleotidesIBA 01/2021
1	Surface-Active Agents (Surfactants)IBA 01/2021
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Reverse Transcriptase InhibitorsIBA 01/2019
1	MTOR InhibitorsIBA 01/2019
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019
1	ChitosanIBA 01/2019
1	Sunscreening Agents (Sunscreens)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	poly(omega- pentadecalactone- co- p- dioxanone)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	GlobinsIBA 01/2018

Therapy/Procedure

22	Therapeutics 03/2022 - 12/2006
14	Drug Therapy (Chemotherapy) 01/2019 - 12/2006
3	Radiotherapy 01/2019 - 01/2017
2	Topical Administration 01/2022 - 08/2012
2	Immunotherapy 01/2021 - 02/2011
2	Intravaginal Administration 08/2012 - 06/2009
2	Blood Vessel Prosthesis 03/2010 - 04/2006
1	Artificial Skin 01/2020
1	Highly Active Antiretroviral Therapy (HAART) 01/2019
1	Stents 01/2019